Evidence map›Paper›PMID 34515726›Full record

ArticleThe Journal of experimental medicine2021

A fungal antigenic driver for Löfgren's syndrome sarcoidosis.

Clarice X Lim, Thomas Weichhart

Abstract readComment
In one paragraph

Article in The Journal of experimental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Aberrant Lipid Metabolism in Macrophages Is Associated with Granuloma Formation in Sarcoidosis.American journal of respiratory and critical care medicine · 2024
    Article
  2. Infectious Complications of Pulmonary Sarcoidosis.Journal of clinical medicine · 2024
    Review
  3. Article
  4. The Role ofMicroorganisms · 2022
    Review
  5. Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.Journal of immunology (Baltimore, Md. : 1950) · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Clarice X LimCenter for Pathobiochemistry & Genetics, Medical University of Vienna, Vienna, Austria.
Thomas WeichhartCenter for Pathobiochemistry & Genetics, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-4349-0797

Funding

Austrian Science Fund FWF P 30857Austrian Science Fund FWF P30857-B28Austrian Science Fund FWF P 34023Austrian Science Fund FWF P 34266
6 · The paper itself

Abstract

Löfgren's syndrome is an acute form of sarcoidosis that is characterized by the activation of CD4+ T helper cells. In this issue of JEM, Greaves et al. (2021. J. Exp. Med.https://doi.org/10.1084/jem.20210785) identified a peptide derived from an airborne mold species that stimulates T cells of Löfgren's syndrome patients in an HLA-DR3-restricted manner. An increased serum IgG antibody response to the full-length protein was also observed in those patients, indicating that the fungus Aspergillus nidulans might be the elusive microbial agent that drives acute sarcoidosis.

Indexed as

SarcoidosisHumansSyndrome

Identifiers

PMID34515726
PMCPMC8493861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.